These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 29684341

  • 1. Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit.
    Al-Zubaidi N, Shehada E, Alshabani K, ZazaDitYafawi J, Kingah P, Soubani AO.
    Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):206-218. PubMed ID: 29684341
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.
    Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC.
    Br J Anaesth; 2012 Mar; 108(3):452-9. PubMed ID: 22298243
    [Abstract] [Full Text] [Related]

  • 5. Hematologic malignancies in the medical intensive care unit--Outcomes and prognostic factors.
    Grgić Medić M, Gornik I, Gašparović V.
    Hematology; 2015 Jun; 20(5):247-53. PubMed ID: 25310461
    [Abstract] [Full Text] [Related]

  • 6. Short- and long-term outcomes in onco-hematological patients admitted to the intensive care unit with classic factors of poor prognosis.
    Faucher E, Cour M, Jahandiez V, Grateau A, Baudry T, Hernu R, Simon M, Robert JM, Michallet M, Argaud L.
    Oncotarget; 2016 Apr 19; 7(16):22427-38. PubMed ID: 26968953
    [Abstract] [Full Text] [Related]

  • 7. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
    Pène F, Aubron C, Azoulay E, Blot F, Thiéry G, Raynard B, Schlemmer B, Nitenberg G, Buzyn A, Arnaud P, Socié G, Mira JP.
    J Clin Oncol; 2006 Feb 01; 24(4):643-9. PubMed ID: 16380411
    [Abstract] [Full Text] [Related]

  • 8. Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?
    Kalicińska E, Kuszczak B, Dębski J, Szukalski Ł, Wątek M, Strzała J, Rybka J, Czyż J, Lech-Marańda E, Zaucha J, Wróbel T.
    Support Care Cancer; 2021 Jan 01; 29(1):323-330. PubMed ID: 32361829
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit.
    Yeo CD, Kim JW, Kim SC, Kim YK, Kim KH, Kim HJ, Lee S, Rhee CK.
    J Crit Care; 2012 Dec 01; 27(6):739.e1-6. PubMed ID: 23217573
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors in critically ill cancer patients admitted to the intensive care unit.
    Aygencel G, Turkoglu M, Turkoz Sucak G, Benekli M.
    J Crit Care; 2014 Aug 01; 29(4):618-26. PubMed ID: 24612762
    [Abstract] [Full Text] [Related]

  • 14. Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study.
    Hill QA, Kelly RJ, Patalappa C, Whittle AM, Scally AJ, Hughes A, Ashcroft AJ, Hill A.
    Leuk Lymphoma; 2012 Feb 01; 53(2):282-8. PubMed ID: 21846185
    [Abstract] [Full Text] [Related]

  • 15. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning.
    Townsend WM, Holroyd A, Pearce R, Mackinnon S, Naik P, Goldstone AH, Linch DC, Peggs KS, Thomson KJ, Singer M, Howell DC, Morris EC.
    Br J Haematol; 2013 May 01; 161(4):578-86. PubMed ID: 23496350
    [Abstract] [Full Text] [Related]

  • 16. Prognosis of hematologic malignancies does not predict intensive care unit mortality.
    Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A, Installé E.
    Crit Care Med; 2002 Oct 01; 30(10):2260-70. PubMed ID: 12394954
    [Abstract] [Full Text] [Related]

  • 17. Determinants of 6-month survival of critically ill patients with an active hematologic malignancy.
    Richards S, Wibrow B, Anstey M, Sidiqi H, Chee A, Ho KM.
    J Crit Care; 2016 Dec 01; 36():252-258. PubMed ID: 27637467
    [Abstract] [Full Text] [Related]

  • 18. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients.
    Afessa B, Tefferi A, Dunn WF, Litzow MR, Peters SG.
    Crit Care Med; 2003 Jun 01; 31(6):1715-21. PubMed ID: 12794410
    [Abstract] [Full Text] [Related]

  • 19. Mortality of Oncohematological Patients Undergoing Hematopoietic Stem Cell Transplantation Admitted to the Intensive Care Unit.
    Corcía Palomo Y, Knight Asorey T, Espigado I, Martín Villén L, Garnacho Montero J.
    Transplant Proc; 2015 Nov 01; 47(9):2665-6. PubMed ID: 26680067
    [Abstract] [Full Text] [Related]

  • 20. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients.
    Lueck C, Stadler M, Koenecke C, Hoeper MM, Dammann E, Schneider A, Kielstein JT, Ganser A, Eder M, Beutel G.
    Intensive Care Med; 2018 Sep 01; 44(9):1483-1492. PubMed ID: 30141173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.